Recent clinical trials and guidelines suggest that patients with diabetes should be treated with multiple antihypertensives to achieve blood pressure target goals in order to reduce risk of cardiovascular disease.
Read More »Issue 176 Item 8 Kids’ Diabetes Risk Tied to Cereal Food Timing
The age at which infants are introduced to cereal foods may affect their risk of developing childhood, or type 1, diabetes. Waiting until the age of 3 to introduce solid foods is recommended.
Read More »Issue 176 Item 9 Insulin Improves Exercise Performance in Diabetics With Heart F
Insulin therapy improves exercise ventilatory efficiency and oxygen uptake in heart failure patients with type 2 diabetes, new research by Italian investigators suggests.
Read More »Issue 176 Item 10 Pioglitazone Improves Cardiovascular Risk Profile For Type 2’s
In addition to improving insulin sensitivity, pioglitazone treatment improves endothelial function in conduit arteries and decreases plasma levels of C-reactive protein.
Read More »Issue 176 Item 11 Cast Better Than Shoe for Diabetic Foot Sores
New research indicates that a nonremovable cast helps diabetic foot sores heal faster than special shoes that are typically used.
Read More »Issue 176 Item 12 Pravastatin Plus Captopril Reduces Lipid Levels in Hypertensiv
A dual therapy regiment of pravastatin and captopril appears to improve lipid and glucose metabolism while decreasing blood pressure.
Read More »Issue 176 Item 13 Diabetes Drugs Mask Severity of Heart Attack
New research suggests that the electrocardiogram may not be an accurate guide if the patient is taking drugs called sulfonylureas for diabetes.
Read More »Issue 176 Item 14 Bristol-Myers Squibb Company Has Recalled Glucophage XR tablet
The FDA has released the following information. Glucophage XR tablets (metformin HCl extended release), 500 mg, 100 count bottles, Rx only, Distributed by: Bristol-Myers Squibb CompanyRecall # D-337-3. See Item #2
Read More »Issue 176 Item 15 Gemcabene Safely Increases HDL, Decreases LDL Levels
Patients with baseline triglyceride levels of 200 mg/dL or more who were treated with 150 mg gemcabene daily had an 18% increase in serum HDL cholesterol levels and a 27% reduction in serum triglyceride levels.
Read More »Issue 175 Item 1 Is HbA1c Affected by Glycemic Instability?
Will fluctuations in blood glucose readings effect the HbA1c ?
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.